The International Symposium on Intensive Care and Emergency Medicine (ISICEM), held every year in March, in Brussels, is established as one of the largest congresses in its field and attracts more than 4600 participants from countries world-wide.

The objectives of this four day symposium are to provide participants with an up to date review of the most recent developments in research, therapy, and management of the critically ill. The meeting is open to all physicians, nurses and other health professionals with an interest in critical care or emergency medicine.

Octapharma has participated in the ISICEM congress for the last 5 years. Exhibiting at this meeting is an important part of our marketing activities. This congress is visited by many of our most important customers and therefore provides us with an excellent opportunity to expose both the company and our products. ISICEM is also an important forum to meet new customers and to update our knowledge and keep abreast of the latest developments and trends in intensive care medicine,” according to Annci Rüdh-Lagerman, who is jointly Organising Octapharma´s presence at this event.

This year Octapharma will have a 40 m2 exhibition space at ISICEM (Booth Nº: 121-124) where we will be providing information on our intensive care products ATenativ, Octaplas and Albumin.  We will also present the interactive site www.dicsepsis.org and offer clinicians the opportunity to sign up s members. The website, which is sponsored by Octapharma, is designed for physicians to build knowledge and engage in dialogue in the complex field of disseminated intravascular coagulation (DIC) and ultimately to achieve better patient outcomes.

Octapharma at ISICEM in 2003.